The global Drug Detection and Analysis market was valued at US$ 11753 million in 2025 and is anticipated to reach US$ 18783 million by 2032, at a CAGR of 7.0% from 2026 to 2032.

Drug Detection and Analysis Market

Drug Detection and Analysis refers to the professional activities or services of systematically testing, identifying, and quantitatively analyzing the chemical, biological, and microbiological characteristics of drugs, active pharmaceutical ingredients (APIs), intermediates, biological products, or related samples. Its core purpose is to verify the safety, efficacy, consistency, and regulatory compliance of drugs, and to provide auditable data support for research and development, production release, registration application, and post-market surveillance.

Gross Profit Margin Levels

The gross profit margins of pharmaceutical testing and analysis services typically exhibit a tiered structure based on "standardization level × technological barriers × compliance delivery complexity." Businesses primarily focused on routine physicochemical/microbiological testing, driven by competitive pricing and high turnover, generally have gross profit margins between 20% and 35%. When services shift to method development and validation, impurity profiling/trace analysis (e.g., LC-MS/MS), bioassays, stability lifecycle management, and registration application data package delivery, the gross profit margins are more commonly between 35% and 50% due to higher equipment investment, stringent methodological and compliance documentation requirements, and higher customer switching costs. Furthermore, by adding a framework of "multi-site global consistency + digital data platform + audit-grade QA/QC + long-term master service provider (MSA)," the overall gross profit margin is more likely to remain high within the leading service provider system.

Industry Drivers

The core drivers of this industry's growth come from three main lines: First, the continuous increase in drug regulatory requirements for methodology, data integrity, and traceability (such as ICH methodological and procedural development requirements) is driving companies to increase their workload in validation and compliance testing and to outsource more. Second, the expansion of innovative drug and biologic pipelines and the increasing complexity of molecular structures have significantly raised the technical threshold for impurity profiles, potency, bioanalysis, and stability management, making the large-scale platform value of external professional laboratories more prominent. Third, in order to shorten the R&D-to-commercialization cycle and reduce fixed laboratory investment and capacity fluctuation risks, companies are continuously shifting analytical testing from "self-built cost centers" to "measurable and deliverable external services," thereby supporting the market to maintain steady growth in the medium term.

This report delivers a comprehensive overview of the global Drug Detection and Analysis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drug Detection and Analysis. The Drug Detection and Analysis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Drug Detection and Analysis market comprehensively. Regional market sizes by Type, by Application, by Detection Objective, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Drug Detection and Analysis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Drug Detection and Analysis Market Report

Report Metric	Details
Report Name	Drug Detection and Analysis Market
Accounted market size in 2025	US$ 11753 million
Forecasted market size in 2032	US$ 18783 million
CAGR	7.0%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Chemical Drug Testing Biopharmaceutical Testing Traditional Chinese Medicine Testing Others
Segment by Detection Objective	Quality Control Testing Safety Testing Effectiveness Testing Others
Segment by Detection Stage	Preclinical Testing Clinical Trial Testing Post-Market Surveillance
Segment by Application	Pharmaceutical Companies Biopharmaceutical Companies Drug Regulatory Authorities Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Eurofins Scientific, SGS, Labcorp, Intertek, WuXi AppTec, Charles River Laboratories, ICON pIc, IQVIA, Medpace, Syneos Health, Frontage Laboratories, Pace Analytical Services, Element Materials Technology, ALS Limited, STERIS, LGC Limited, Almac Group, Catalent, Cambrex, Alcami, Toxikon, Boston Analytical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Detection Objective, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Drug Detection and Analysis companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Drug Detection and Analysis Market growing?

Ans: The Drug Detection and Analysis Market witnessing a CAGR of 7.0% during the forecast period 2026-2032.

What is the Drug Detection and Analysis Market size in 2032?

Ans: The Drug Detection and Analysis Market size in 2032 will be US$ 18783 million.

Who are the main players in the Drug Detection and Analysis Market report?

Ans: The main players in the Drug Detection and Analysis Market are Eurofins Scientific, SGS, Labcorp, Intertek, WuXi AppTec, Charles River Laboratories, ICON pIc, IQVIA, Medpace, Syneos Health, Frontage Laboratories, Pace Analytical Services, Element Materials Technology, ALS Limited, STERIS, LGC Limited, Almac Group, Catalent, Cambrex, Alcami, Toxikon, Boston Analytical

What are the Application segmentation covered in the Drug Detection and Analysis Market report?

Ans: The Applications covered in the Drug Detection and Analysis Market report are Pharmaceutical Companies, Biopharmaceutical Companies, Drug Regulatory Authorities, Others

What are the Type segmentation covered in the Drug Detection and Analysis Market report?

Ans: The Types covered in the Drug Detection and Analysis Market report are Chemical Drug Testing, Biopharmaceutical Testing, Traditional Chinese Medicine Testing, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug Detection and Analysis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Chemical Drug Testing

1.2.3 Biopharmaceutical Testing

1.2.4 Traditional Chinese Medicine Testing

1.2.5 Others

1.3 Market by Detection Objective

1.3.1 Global Drug Detection and Analysis Market Size Growth Rate by Detection Objective: 2021 vs 2025 vs 2032

1.3.2 Quality Control Testing

1.3.3 Safety Testing

1.3.4 Effectiveness Testing

1.3.5 Others

1.4 Market by Detection Stage

1.4.1 Global Drug Detection and Analysis Market Size Growth Rate by Detection Stage: 2021 vs 2025 vs 2032

1.4.2 Preclinical Testing

1.4.3 Clinical Trial Testing

1.4.4 Post-Market Surveillance

1.5 Market by Application

1.5.1 Global Drug Detection and Analysis Market Growth by Application: 2021 vs 2025 vs 2032

1.5.2 Pharmaceutical Companies

1.5.3 Biopharmaceutical Companies

1.5.4 Drug Regulatory Authorities

1.5.5 Others

1.6 Assumptions and Limitations

1.7 Study Objectives

1.8 Years Considered

2 Global Growth Trends

2.1 Global Drug Detection and Analysis Market Perspective (2021–2032)

2.2 Global Drug Detection and Analysis Growth Trends by Region

2.2.1 Global Drug Detection and Analysis Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Drug Detection and Analysis Historic Market Size by Region (2021–2026)

2.2.3 Drug Detection and Analysis Forecasted Market Size by Region (2027–2032)

2.3 Drug Detection and Analysis Market Dynamics

2.3.1 Drug Detection and Analysis Industry Trends

2.3.2 Drug Detection and Analysis Market Drivers

2.3.3 Drug Detection and Analysis Market Challenges

2.3.4 Drug Detection and Analysis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug Detection and Analysis Players by Revenue

3.1.1 Global Top Drug Detection and Analysis Players by Revenue (2021–2026)

3.1.2 Global Drug Detection and Analysis Revenue Market Share by Players (2021–2026)

3.2 Global Top Drug Detection and Analysis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Drug Detection and Analysis Revenue

3.4 Global Drug Detection and Analysis Market Concentration Ratio

3.4.1 Global Drug Detection and Analysis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug Detection and Analysis Revenue in 2025

3.5 Global Key Players of Drug Detection and Analysis Head Offices and Areas Served

3.6 Global Key Players of Drug Detection and Analysis, Products and Applications

3.7 Global Key Players of Drug Detection and Analysis, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Drug Detection and Analysis Breakdown Data by Type

4.1 Global Drug Detection and Analysis Historic Market Size by Type (2021–2026)

4.2 Global Drug Detection and Analysis Forecasted Market Size by Type (2027–2032)

5 Drug Detection and Analysis Breakdown Data by Application

5.1 Global Drug Detection and Analysis Historic Market Size by Application (2021–2026)

5.2 Global Drug Detection and Analysis Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Drug Detection and Analysis Market Size (2021–2032)

6.2 North America Drug Detection and Analysis Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Drug Detection and Analysis Market Size by Country (2021–2026)

6.4 North America Drug Detection and Analysis Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug Detection and Analysis Market Size (2021–2032)

7.2 Europe Drug Detection and Analysis Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Drug Detection and Analysis Market Size by Country (2021–2026)

7.4 Europe Drug Detection and Analysis Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Drug Detection and Analysis Market Size (2021–2032)

8.2 Asia-Pacific Drug Detection and Analysis Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Drug Detection and Analysis Market Size by Region (2021–2026)

8.4 Asia-Pacific Drug Detection and Analysis Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Drug Detection and Analysis Market Size (2021–2032)

9.2 Latin America Drug Detection and Analysis Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Drug Detection and Analysis Market Size by Country (2021–2026)

9.4 Latin America Drug Detection and Analysis Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug Detection and Analysis Market Size (2021–2032)

10.2 Middle East & Africa Drug Detection and Analysis Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Drug Detection and Analysis Market Size by Country (2021–2026)

10.4 Middle East & Africa Drug Detection and Analysis Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Eurofins Scientific

11.1.1 Eurofins Scientific Company Details

11.1.2 Eurofins Scientific Business Overview

11.1.3 Eurofins Scientific Drug Detection and Analysis Introduction

11.1.4 Eurofins Scientific Revenue in Drug Detection and Analysis Business (2021–2026)

11.1.5 Eurofins Scientific Recent Development

11.2 SGS

11.2.1 SGS Company Details

11.2.2 SGS Business Overview

11.2.3 SGS Drug Detection and Analysis Introduction

11.2.4 SGS Revenue in Drug Detection and Analysis Business (2021–2026)

11.2.5 SGS Recent Development

11.3 Labcorp

11.3.1 Labcorp Company Details

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Drug Detection and Analysis Introduction

11.3.4 Labcorp Revenue in Drug Detection and Analysis Business (2021–2026)

11.3.5 Labcorp Recent Development

11.4 Intertek

11.4.1 Intertek Company Details

11.4.2 Intertek Business Overview

11.4.3 Intertek Drug Detection and Analysis Introduction

11.4.4 Intertek Revenue in Drug Detection and Analysis Business (2021–2026)

11.4.5 Intertek Recent Development

11.5 WuXi AppTec

11.5.1 WuXi AppTec Company Details

11.5.2 WuXi AppTec Business Overview

11.5.3 WuXi AppTec Drug Detection and Analysis Introduction

11.5.4 WuXi AppTec Revenue in Drug Detection and Analysis Business (2021–2026)

11.5.5 WuXi AppTec Recent Development

11.6 Charles River Laboratories

11.6.1 Charles River Laboratories Company Details

11.6.2 Charles River Laboratories Business Overview

11.6.3 Charles River Laboratories Drug Detection and Analysis Introduction

11.6.4 Charles River Laboratories Revenue in Drug Detection and Analysis Business (2021–2026)

11.6.5 Charles River Laboratories Recent Development

11.7 ICON pIc

11.7.1 ICON pIc Company Details

11.7.2 ICON pIc Business Overview

11.7.3 ICON pIc Drug Detection and Analysis Introduction

11.7.4 ICON pIc Revenue in Drug Detection and Analysis Business (2021–2026)

11.7.5 ICON pIc Recent Development

11.8 IQVIA

11.8.1 IQVIA Company Details

11.8.2 IQVIA Business Overview

11.8.3 IQVIA Drug Detection and Analysis Introduction

11.8.4 IQVIA Revenue in Drug Detection and Analysis Business (2021–2026)

11.8.5 IQVIA Recent Development

11.9 Medpace

11.9.1 Medpace Company Details

11.9.2 Medpace Business Overview

11.9.3 Medpace Drug Detection and Analysis Introduction

11.9.4 Medpace Revenue in Drug Detection and Analysis Business (2021–2026)

11.9.5 Medpace Recent Development

11.10 Syneos Health

11.10.1 Syneos Health Company Details

11.10.2 Syneos Health Business Overview

11.10.3 Syneos Health Drug Detection and Analysis Introduction

11.10.4 Syneos Health Revenue in Drug Detection and Analysis Business (2021–2026)

11.10.5 Syneos Health Recent Development

11.11 Frontage Laboratories

11.11.1 Frontage Laboratories Company Details

11.11.2 Frontage Laboratories Business Overview

11.11.3 Frontage Laboratories Drug Detection and Analysis Introduction

11.11.4 Frontage Laboratories Revenue in Drug Detection and Analysis Business (2021–2026)

11.11.5 Frontage Laboratories Recent Development

11.12 Pace Analytical Services

11.12.1 Pace Analytical Services Company Details

11.12.2 Pace Analytical Services Business Overview

11.12.3 Pace Analytical Services Drug Detection and Analysis Introduction

11.12.4 Pace Analytical Services Revenue in Drug Detection and Analysis Business (2021–2026)

11.12.5 Pace Analytical Services Recent Development

11.13 Element Materials Technology

11.13.1 Element Materials Technology Company Details

11.13.2 Element Materials Technology Business Overview

11.13.3 Element Materials Technology Drug Detection and Analysis Introduction

11.13.4 Element Materials Technology Revenue in Drug Detection and Analysis Business (2021–2026)

11.13.5 Element Materials Technology Recent Development

11.14 ALS Limited

11.14.1 ALS Limited Company Details

11.14.2 ALS Limited Business Overview

11.14.3 ALS Limited Drug Detection and Analysis Introduction

11.14.4 ALS Limited Revenue in Drug Detection and Analysis Business (2021–2026)

11.14.5 ALS Limited Recent Development

11.15 STERIS

11.15.1 STERIS Company Details

11.15.2 STERIS Business Overview

11.15.3 STERIS Drug Detection and Analysis Introduction

11.15.4 STERIS Revenue in Drug Detection and Analysis Business (2021–2026)

11.15.5 STERIS Recent Development

11.16 LGC Limited

11.16.1 LGC Limited Company Details

11.16.2 LGC Limited Business Overview

11.16.3 LGC Limited Drug Detection and Analysis Introduction

11.16.4 LGC Limited Revenue in Drug Detection and Analysis Business (2021–2026)

11.16.5 LGC Limited Recent Development

11.17 Almac Group

11.17.1 Almac Group Company Details

11.17.2 Almac Group Business Overview

11.17.3 Almac Group Drug Detection and Analysis Introduction

11.17.4 Almac Group Revenue in Drug Detection and Analysis Business (2021–2026)

11.17.5 Almac Group Recent Development

11.18 Catalent

11.18.1 Catalent Company Details

11.18.2 Catalent Business Overview

11.18.3 Catalent Drug Detection and Analysis Introduction

11.18.4 Catalent Revenue in Drug Detection and Analysis Business (2021–2026)

11.18.5 Catalent Recent Development

11.19 Cambrex

11.19.1 Cambrex Company Details

11.19.2 Cambrex Business Overview

11.19.3 Cambrex Drug Detection and Analysis Introduction

11.19.4 Cambrex Revenue in Drug Detection and Analysis Business (2021–2026)

11.19.5 Cambrex Recent Development

11.20 Alcami

11.20.1 Alcami Company Details

11.20.2 Alcami Business Overview

11.20.3 Alcami Drug Detection and Analysis Introduction

11.20.4 Alcami Revenue in Drug Detection and Analysis Business (2021–2026)

11.20.5 Alcami Recent Development

11.21 Toxikon

11.21.1 Toxikon Company Details

11.21.2 Toxikon Business Overview

11.21.3 Toxikon Drug Detection and Analysis Introduction

11.21.4 Toxikon Revenue in Drug Detection and Analysis Business (2021–2026)

11.21.5 Toxikon Recent Development

11.22 Boston Analytical

11.22.1 Boston Analytical Company Details

11.22.2 Boston Analytical Business Overview

11.22.3 Boston Analytical Drug Detection and Analysis Introduction

11.22.4 Boston Analytical Revenue in Drug Detection and Analysis Business (2021–2026)

11.22.5 Boston Analytical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Element Materials Technology

Intertek

Eurofins Scientific

Charles River Laboratories

Frontage Laboratories

Pace Analytical Services

List of Tables

Table 1. Global Drug Detection and Analysis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Chemical Drug Testing

Table 3. Key Players of Biopharmaceutical Testing

Table 4. Key Players of Traditional Chinese Medicine Testing

Table 5. Key Players of Others

Table 6. Global Drug Detection and Analysis Market Size Growth Rate by Detection Objective (US$ Million): 2021 vs 2025 vs 2032

Table 7. Key Players of Quality Control Testing

Table 8. Key Players of Safety Testing

Table 9. Key Players of Effectiveness Testing

Table 10. Key Players of Others

Table 11. Global Drug Detection and Analysis Market Size Growth Rate by Detection Stage (US$ Million): 2021 vs 2025 vs 2032

Table 12. Key Players of Preclinical Testing

Table 13. Key Players of Clinical Trial Testing

Table 14. Key Players of Post-Market Surveillance

Table 15. Global Drug Detection and Analysis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global Drug Detection and Analysis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 17. Global Drug Detection and Analysis Market Size by Region (US$ Million), 2021–2026

Table 18. Global Drug Detection and Analysis Market Share by Region (2021–2026)

Table 19. Global Drug Detection and Analysis Forecasted Market Size by Region (US$ Million), 2027–2032

Table 20. Global Drug Detection and Analysis Market Share by Region (2027–2032)

Table 21. Drug Detection and Analysis Market Trends

Table 22. Drug Detection and Analysis Market Drivers

Table 23. Drug Detection and Analysis Market Challenges

Table 24. Drug Detection and Analysis Market Restraints

Table 25. Global Drug Detection and Analysis Revenue by Players (US$ Million), 2021–2026

Table 26. Global Drug Detection and Analysis Market Share by Players (2021–2026)

Table 27. Global Top Drug Detection and Analysis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Drug Detection and Analysis Revenue, 2025

Table 28. Ranking of Global Top Drug Detection and Analysis Companies by Revenue (US$ Million) in 2025

Table 29. Global 5 Largest Players Market Share by Drug Detection and Analysis Revenue (CR5 and HHI), 2021–2026

Table 30. Global Key Players of Drug Detection and Analysis, Headquarters and Area Served

Table 31. Global Key Players of Drug Detection and Analysis, Products and Applications

Table 32. Global Key Players of Drug Detection and Analysis, Date of General Availability (GA)

Table 33. Mergers and Acquisitions, Expansion Plans

Table 34. Global Drug Detection and Analysis Market Size by Type (US$ Million), 2021–2026

Table 35. Global Drug Detection and Analysis Revenue Market Share by Type (2021–2026)

Table 36. Global Drug Detection and Analysis Forecasted Market Size by Type (US$ Million), 2027–2032

Table 37. Global Drug Detection and Analysis Revenue Market Share by Type (2027–2032)

Table 38. Global Drug Detection and Analysis Market Size by Application (US$ Million), 2021–2026

Table 39. Global Drug Detection and Analysis Revenue Market Share by Application (2021–2026)

Table 40. Global Drug Detection and Analysis Forecasted Market Size by Application (US$ Million), 2027–2032

Table 41. Global Drug Detection and Analysis Revenue Market Share by Application (2027–2032)

Table 42. North America Drug Detection and Analysis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 43. North America Drug Detection and Analysis Market Size by Country (US$ Million), 2021–2026

Table 44. North America Drug Detection and Analysis Market Size by Country (US$ Million), 2027–2032

Table 45. Europe Drug Detection and Analysis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 46. Europe Drug Detection and Analysis Market Size by Country (US$ Million), 2021–2026

Table 47. Europe Drug Detection and Analysis Market Size by Country (US$ Million), 2027–2032

Table 48. Asia-Pacific Drug Detection and Analysis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 49. Asia-Pacific Drug Detection and Analysis Market Size by Region (US$ Million), 2021–2026

Table 50. Asia-Pacific Drug Detection and Analysis Market Size by Region (US$ Million), 2027–2032

Table 51. Latin America Drug Detection and Analysis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 52. Latin America Drug Detection and Analysis Market Size by Country (US$ Million), 2021–2026

Table 53. Latin America Drug Detection and Analysis Market Size by Country (US$ Million), 2027–2032

Table 54. Middle East & Africa Drug Detection and Analysis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 55. Middle East & Africa Drug Detection and Analysis Market Size by Country (US$ Million), 2021–2026

Table 56. Middle East & Africa Drug Detection and Analysis Market Size by Country (US$ Million), 2027–2032

Table 57. Eurofins Scientific Company Details

Table 58. Eurofins Scientific Business Overview

Table 59. Eurofins Scientific Drug Detection and Analysis Product

Table 60. Eurofins Scientific Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 61. Eurofins Scientific Recent Development

Table 62. SGS Company Details

Table 63. SGS Business Overview

Table 64. SGS Drug Detection and Analysis Product

Table 65. SGS Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 66. SGS Recent Development

Table 67. Labcorp Company Details

Table 68. Labcorp Business Overview

Table 69. Labcorp Drug Detection and Analysis Product

Table 70. Labcorp Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 71. Labcorp Recent Development

Table 72. Intertek Company Details

Table 73. Intertek Business Overview

Table 74. Intertek Drug Detection and Analysis Product

Table 75. Intertek Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 76. Intertek Recent Development

Table 77. WuXi AppTec Company Details

Table 78. WuXi AppTec Business Overview

Table 79. WuXi AppTec Drug Detection and Analysis Product

Table 80. WuXi AppTec Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 81. WuXi AppTec Recent Development

Table 82. Charles River Laboratories Company Details

Table 83. Charles River Laboratories Business Overview

Table 84. Charles River Laboratories Drug Detection and Analysis Product

Table 85. Charles River Laboratories Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 86. Charles River Laboratories Recent Development

Table 87. ICON pIc Company Details

Table 88. ICON pIc Business Overview

Table 89. ICON pIc Drug Detection and Analysis Product

Table 90. ICON pIc Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 91. ICON pIc Recent Development

Table 92. IQVIA Company Details

Table 93. IQVIA Business Overview

Table 94. IQVIA Drug Detection and Analysis Product

Table 95. IQVIA Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 96. IQVIA Recent Development

Table 97. Medpace Company Details

Table 98. Medpace Business Overview

Table 99. Medpace Drug Detection and Analysis Product

Table 100. Medpace Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 101. Medpace Recent Development

Table 102. Syneos Health Company Details

Table 103. Syneos Health Business Overview

Table 104. Syneos Health Drug Detection and Analysis Product

Table 105. Syneos Health Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 106. Syneos Health Recent Development

Table 107. Frontage Laboratories Company Details

Table 108. Frontage Laboratories Business Overview

Table 109. Frontage Laboratories Drug Detection and Analysis Product

Table 110. Frontage Laboratories Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 111. Frontage Laboratories Recent Development

Table 112. Pace Analytical Services Company Details

Table 113. Pace Analytical Services Business Overview

Table 114. Pace Analytical Services Drug Detection and Analysis Product

Table 115. Pace Analytical Services Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 116. Pace Analytical Services Recent Development

Table 117. Element Materials Technology Company Details

Table 118. Element Materials Technology Business Overview

Table 119. Element Materials Technology Drug Detection and Analysis Product

Table 120. Element Materials Technology Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 121. Element Materials Technology Recent Development

Table 122. ALS Limited Company Details

Table 123. ALS Limited Business Overview

Table 124. ALS Limited Drug Detection and Analysis Product

Table 125. ALS Limited Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 126. ALS Limited Recent Development

Table 127. STERIS Company Details

Table 128. STERIS Business Overview

Table 129. STERIS Drug Detection and Analysis Product

Table 130. STERIS Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 131. STERIS Recent Development

Table 132. LGC Limited Company Details

Table 133. LGC Limited Business Overview

Table 134. LGC Limited Drug Detection and Analysis Product

Table 135. LGC Limited Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 136. LGC Limited Recent Development

Table 137. Almac Group Company Details

Table 138. Almac Group Business Overview

Table 139. Almac Group Drug Detection and Analysis Product

Table 140. Almac Group Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 141. Almac Group Recent Development

Table 142. Catalent Company Details

Table 143. Catalent Business Overview

Table 144. Catalent Drug Detection and Analysis Product

Table 145. Catalent Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 146. Catalent Recent Development

Table 147. Cambrex Company Details

Table 148. Cambrex Business Overview

Table 149. Cambrex Drug Detection and Analysis Product

Table 150. Cambrex Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 151. Cambrex Recent Development

Table 152. Alcami Company Details

Table 153. Alcami Business Overview

Table 154. Alcami Drug Detection and Analysis Product

Table 155. Alcami Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 156. Alcami Recent Development

Table 157. Toxikon Company Details

Table 158. Toxikon Business Overview

Table 159. Toxikon Drug Detection and Analysis Product

Table 160. Toxikon Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 161. Toxikon Recent Development

Table 162. Boston Analytical Company Details

Table 163. Boston Analytical Business Overview

Table 164. Boston Analytical Drug Detection and Analysis Product

Table 165. Boston Analytical Revenue in Drug Detection and Analysis Business (US$ Million), 2021–2026

Table 166. Boston Analytical Recent Development

Table 167. Research Programs/Design for This Report

Table 168. Key Data Information from Secondary Sources

Table 169. Key Data Information from Primary Sources

Table 170. Authors List of This Report

List of Figures

Figure 1. Drug Detection and Analysis Picture

Figure 2. Global Drug Detection and Analysis Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Drug Detection and Analysis Market Share by Type: 2025 vs 2032

Figure 4. Chemical Drug Testing Features

Figure 5. Biopharmaceutical Testing Features

Figure 6. Traditional Chinese Medicine Testing Features

Figure 7. Others Features

Figure 8. Global Drug Detection and Analysis Market Size Comparison by Detection Objective (US$ Million), 2021–2032

Figure 9. Quality Control Testing Features

Figure 10. Safety Testing Features

Figure 11. Effectiveness Testing Features

Figure 12. Others Features

Figure 13. Global Drug Detection and Analysis Market Size Comparison by Detection Stage (US$ Million), 2021–2032

Figure 14. Preclinical Testing Features

Figure 15. Clinical Trial Testing Features

Figure 16. Post-Market Surveillance Features

Figure 17. Global Drug Detection and Analysis Market Size by Application (US$ Million), 2021–2032

Figure 18. Global Drug Detection and Analysis Market Share by Application: 2025 vs 2032

Figure 19. Pharmaceutical Companies Case Studies

Figure 20. Biopharmaceutical Companies Case Studies

Figure 21. Drug Regulatory Authorities Case Studies

Figure 22. Others Case Studies

Figure 23. Drug Detection and Analysis Report Years Considered

Figure 24. Global Drug Detection and Analysis Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 25. Global Drug Detection and Analysis Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 26. Global Drug Detection and Analysis Market Share by Region: 2025 vs 2032

Figure 27. Global Drug Detection and Analysis Market Share by Players in 2025

Figure 28. Global Drug Detection and Analysis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 29. The Top 10 and 5 Players Market Share by Drug Detection and Analysis Revenue in 2025

Figure 30. North America Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. North America Drug Detection and Analysis Market Share by Country (2021–2032)

Figure 32. United States Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Canada Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. Europe Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Europe Drug Detection and Analysis Market Share by Country (2021–2032)

Figure 36. Germany Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. France Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. U.K. Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Italy Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Russia Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Ireland Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Asia-Pacific Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Asia-Pacific Drug Detection and Analysis Market Share by Region (2021–2032)

Figure 44. China Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Japan Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. South Korea Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Southeast Asia Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. India Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 49. Australia & New Zealand Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Latin America Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Latin America Drug Detection and Analysis Market Share by Country (2021–2032)

Figure 52. Mexico Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 53. Brazil Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Middle East & Africa Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. Middle East & Africa Drug Detection and Analysis Market Share by Country (2021–2032)

Figure 56. Israel Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 57. Saudi Arabia Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 58. UAE Drug Detection and Analysis Market Size YoY Growth (US$ Million), 2021–2032

Figure 59. Eurofins Scientific Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 60. SGS Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 61. Labcorp Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 62. Intertek Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 63. WuXi AppTec Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 64. Charles River Laboratories Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 65. ICON pIc Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 66. IQVIA Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 67. Medpace Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 68. Syneos Health Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 69. Frontage Laboratories Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 70. Pace Analytical Services Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 71. Element Materials Technology Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 72. ALS Limited Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 73. STERIS Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 74. LGC Limited Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 75. Almac Group Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 76. Catalent Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 77. Cambrex Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 78. Alcami Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 79. Toxikon Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 80. Boston Analytical Revenue Growth Rate in Drug Detection and Analysis Business (2021–2026)

Figure 81. Bottom-up and Top-down Approaches for This Report

Figure 82. Data Triangulation

Figure 83. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Drug Analyzer Market Research Report 2025

Drug Tester Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Concentration Detection Market Research Report 2024

Global Drug Detector Market Insights Forecast to 2030

Global Drug Trace Analyzer Market Research Report 2025

Global Biological Sample Drug Detector Market Research Report 2025

Blood Drug Concentration Monitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Drug Screening System Market Research Report 2025

Global Drug Concentration Analysis System Market Research Report 2024

Drug Testing Market

Global Hair Drug Trace Analyzer Market Research Report 2025

Global Narcotics Analyzer Market Research Report 2025

Global Drug Testing System Market Insights Forecast to 2030

Medical Urine Analyzers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Portable Drug Trace Analyzer Market Research Report 2025

Drug Test Chambers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Analysis System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Blood Sample Analyzer Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Analytical Instruments for Drug Screening Market

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions